NASDAQ:SLGL - Sol Gel Technologies Stock Price, Forecast & News

Sol Gel Technologies trades on the NASDAQ under the ticker symbol "SLGL."

Sol Gel Technologies Ltd (NASDAQ:SLGL) posted its quarterly earnings results on Wednesday, November, 13th. The company reported ($0.37) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.25) by $0.12. The company earned $4.73 million during the quarter, compared to the consensus estimate of $6.56 million. Sol Gel Technologies had a negative net margin of 223.99% and a negative return on equity of 71.98%. View Sol Gel Technologies' Earnings History.

Sol Gel Technologies is scheduled to release their next quarterly earnings announcement on Thursday, March 19th 2020. View Earnings Estimates for Sol Gel Technologies.

4 equities research analysts have issued 1-year price objectives for Sol Gel Technologies' shares. Their forecasts range from $23.00 to $33.00. On average, they anticipate Sol Gel Technologies' stock price to reach $26.50 in the next twelve months. This suggests a possible upside of 101.5% from the stock's current price. View Analyst Price Targets for Sol Gel Technologies.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sol Gel Technologies in the last year. There are currently 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sol Gel Technologies.

Media coverage about SLGL stock has been trending somewhat positive on Wednesday, InfoTrie Sentiment reports. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Sol Gel Technologies earned a coverage optimism score of 1.0 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for Sol Gel Technologies.

Sol Gel Technologies saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 53,800 shares, an increase of 10.5% from the December 15th total of 48,700 shares. Based on an average trading volume of 80,700 shares, the short-interest ratio is presently 0.7 days. Approximately 1.4% of the shares of the company are sold short. View Sol Gel Technologies' Current Options Chain.

Some companies that are related to Sol Gel Technologies include XBiotech (XBIT), G1 Therapeutics (GTHX), Amphastar Pharmaceuticals (AMPH), Gossamer Bio (GOSS), Akebia Therapeutics (AKBA), Odonate Therapeutics (ODT), Radius Health (RDUS), Achillion Pharmaceuticals (ACHN), Phathom Pharmaceuticals (PHAT), Rhythm Pharmaceuticals (RYTM), Kiniksa Pharmaceuticals (KNSA), Aprea Therapeutics (APRE), Applied Therapeutics (APLT), Provention Bio (PRVB) and Dova Pharmaceuticals (DOVA).

Based on aggregate information from My MarketBeat watchlists, some companies that other Sol Gel Technologies investors own include Amarin (AMRN), Iovance Biotherapeutics (IOVA), NVIDIA (NVDA), Applied Optoelectronics (AAOI), Adaptimmune Therapeutics (ADAP), Aqua Metals (AQMS), Arena Pharmaceuticals (ARNA), Inovio Pharmaceuticals (INO), Ligand Pharmaceuticals (LGND) and Mylan (MYL).

(SLGL) raised $60 million in an IPO on Thursday, February 1st 2018. The company issued 5,000,000 shares at a price of $11.00-$13.00 per share. ​Jefferies and BMO Capital Markets​ served as the underwriters for the IPO and JMP Securities and Raymond James​ were co-managers.

Shares of SLGL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of SLGL stock can currently be purchased for approximately $13.15.

Sol Gel Technologies has a market capitalization of $248.84 million and generates $130,000.00 in revenue each year. The company earns $-32,200,000.00 in net income (profit) each year or ($1.80) on an earnings per share basis. View Additional Information About Sol Gel Technologies.

The official website for Sol Gel Technologies is http://www.sol-gel.com/.

Sol Gel Technologies' mailing address is 7 GOLDA MEIR ST. WEIZMANN SCIENCE PARK, NESS ZIONA L3, 7403650. The company can be reached via phone at 972-8931-3429 or via email at [email protected]